BTAI
BioXcel Therapeutics, Inc. SEC filings
Every EDGAR filing for BioXcel Therapeutics, Inc. (BTAI), newest first, with AI summaries and stories.
- Ticker
- BTAI
- CIK
- 1720893
- Latest filing
- Sep 1
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 2 insider filings
Susan E. Atkins, insider filing for BTAI
Show all 2
- 4Insider filing for BTAI
- 3New insider at BTAI
Susan E. Atkins, reporting
ROUTINESCHEDULE 13G/ABioXcel Therapeutics, Inc.BTAILIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
NOTABLE10-QBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 4 insider filings
Javier Rodriguez, insider filing for BTAI
Show all 4
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
Javier Rodriguez, reporting
ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 4 insider filings
Frank Yocca, insider filing for BTAI
Show all 4
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
Frank Yocca, reporting
ROUTINE144BioXcel Therapeutics, Inc.BTAILIVE 4 Form 144 notices
Vimal Mehta, planned sale of BTAI shares
Show all 4
- 144Planned insider sale of BTAI shares
- 144Planned insider sale of BTAI shares
- 144Planned insider sale of BTAI shares
- 144Planned insider sale of BTAI shares
Vimal Mehta, reporting
ROUTINESCHEDULE 13GBioXcel Therapeutics, Inc.BTAILIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by
ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE NOTABLE10-QBioXcel Therapeutics, Inc.BTAILIVE ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 4 insider filings
Vimal Mehta, insider filing for BTAI
Show all 4
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
Vimal Mehta, reporting
ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINESCHEDULE 13G/ABioXcel Therapeutics, Inc.BTAILIVE Ownership stake disclosure by Qatar Investment Authority (amended)
Qatar Investment Authority, filed by
ROUTINES-8BioXcel Therapeutics, Inc.BTAILIVE NOTABLE10-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 4 insider filings
Vimal Mehta, insider filing for BTAI
Show all 4
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
Vimal Mehta, reporting
ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE424B5BioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINESCHEDULE 13G/ABioXcel Therapeutics, Inc.BTAILIVE Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)
INTEGRATED CORE STRATEGIES (US) LLC, filed by
ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE8-KBioXcel Therapeutics, Inc.BTAILIVE ROUTINE4BioXcel Therapeutics, Inc.BTAILIVE 4 insider filings
Sandeep Laumas, insider filing for BTAI
Show all 4
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
- 4Insider filing for BTAI
Sandeep Laumas, reporting